Share Prices & Company Research

Market News

08 Mar 2021 | 11:48

AstraZeneca vaccine reportedly effective against Brazilian Covid-19 strain

(Sharecast News) - The Covid-19 vaccine developed by AstraZeneca and the University of Oxford does protect against the new strain of the virus detected in the South American, the results of a study conducted by Oxford researchers showed. Speaking to Reuters, a source with knowledge of the study, also said that vaccine therefore does not need to be modified.

Results from the study might be made public as soon as March.

The same source did not provide the exact efficacy of the vaccine against the so-called P1 variant, which is also known as 20J/501Y.V3.

Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 14th May 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.